Impact of preconception thyrotrophin on obstetric outcomes in the fertile population

Endocrinol Diabetes Nutr (Engl Ed). 2023 Apr;70(4):262-269. doi: 10.1016/j.endien.2023.03.014. Epub 2023 Apr 4.

Abstract

Introduction: There is evidence that subclinical hypothyroidism is associated with infertility, miscarriage and obstetric complications. However, there is controversy regarding the optimal TSH value in women seeking pregnancy. Current guidelines recommend that hypothyroid women with levothyroxine replacement who are planning pregnancy should optimise the dose of levothyroxine to achieve thyrotrophin (TSH) levels <2.5 mU/l, since these requirements increase in pregnancy, thus reducing the risk of TSH elevation during the first trimester. In women with infertility, who undergo highly complex treatments and have positive thyroid autoimmunity, values of TSH <2.5 mU/l prior to fertility treatment are suggested. Although this is a different population, these «optimal» TSH levels were also extended to euthyroid women without evidence of infertility, who are seeking pregnancy.

Objectives: Determine whether preconception TSH levels between 2.5 and 4.64 mIU/l are associated with adverse obstetric outcomes in euthyroid women.

Materials and methods: Retrospective cohort study. We evaluated 3265 medical records of pregnant women aged 18-40 years, euthyroid (TSH 0.5-4.64 mU/ml), with TSH measurement at least one year before gestation. 1779 met inclusion criteria. The population was divided according to categories: TSH 0.5-2.4 mU/l (optimal) and TSH 2.5-4.6 mU/l (suboptimal). Information on maternal and fetal obstetric outcomes was collected from each group.

Results: We found no statistical difference in the occurrence of adverse obstetric events between the two groups. There was also no difference when adjusting for thyroid autoimmunity, age, body mass index, previous diabetes and previous arterial hypertension.

Conclusion: Our results suggest that the reference range of TSH used in the general population could be used in women seeking pregnancy, even in the presence of thyroid autoimmunity. Treatment with levothyroxine should be considered only in patients with special situations.

Keywords: Edad reproductiva; Embarazo; Embarazo y tiroides; Euthyroid; Eutiroidismo; Pregnancy; Reproductive age; Thyroid and pregnancy.

MeSH terms

  • Female
  • Humans
  • Hypothyroidism* / chemically induced
  • Hypothyroidism* / complications
  • Hypothyroidism* / drug therapy
  • Infertility* / chemically induced
  • Infertility* / drug therapy
  • Pregnancy
  • Retrospective Studies
  • Thyrotropin
  • Thyroxine / therapeutic use

Substances

  • Thyrotropin
  • Thyroxine